S

Spruce Biosciences Inc
D

SPRB

80.380
USD
2.95
(3.81%)
مغلق
حجم التداول
0
الربح لكل سهم
-42
العائد الربحي
-
P/E
-1
حجم السوق
86,036,341
المقالات

العنوان: Spruce Biosciences Inc

القطاع: Healthcare
الصناعة: Biotechnology
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT), and Tildacerfont/ Cortibon, a Companion Diagnostic, developed in partnership with HMNC Brain Health.